Mike Degraffenreid Email and Phone Number
Scientist, Medicinal Chemistry
at
Unity Biotechnology
Mike Degraffenreid's email is wakeupdreaming@yahoo.com
.
Mike Degraffenreid Contact Details
Email
wakeupdreaming@yahoo.com
Email
mdegraff@amgen.com
Mike Degraffenreid Company Details
Company
Location
South San Francisco, California, United States
Website
Industry
Biotechnology
Mike Degraffenreid's Current Company
Unity Biotechnology
Industry | Biotechnology | |
Location | South San Francisco, California, United States |
Industry | Biotechnology | |
Location | South San Francisco, California, United States |
Mike Degraffenreid's Experience and Education
Scientist, Medicinal Chemistry
2016-12 to 2017-04
South San Francisco, California, United States
Combinatorial Chemistry Production Assistant
1997 to 1998
France, Aquitaine, France
1991 to 1996
San Luis Obispo, California, United States
Frequently Asked Questions about Mike Degraffenreid
What company does Mike Degraffenreid work for?
Mike Degraffenreid works for Unity Biotechnology
What is Mike Degraffenreid's role in his workplace?
Mike Degraffenreid's role in his workplace is
Scientist, Medicinal Chemistry .
Which industry does Mike Degraffenreid work in currently?
Mike Degraffenreid works in the industry
Biotechnology.
What is Mike Degraffenreid's email address?
Mike Degraffenreid's email address is wakeupdreaming@yahoo.com
What schools did Mike Degraffenreid attended?
Mike Degraffenreid attended
Bellarmine College Preparatory,
and
California Polytechnic State University San Luis Obispo.
What are some of Mike Degraffenreid's skills?
Mike Degraffenreid has skills like
Sales,
Drug Development,
Medicinal Chemistry,
and
Drug Discovery.
Who are Mike Degraffenreid's colleagues?
Mike Degraffenreid's colleagues are
Akbar Khan,
Raymond Chen,
Nathan Gushwa,
Ian Steele,
Tianna Chow,
Angela Noury,
and
Scott Kimura.
Who are Mike Degraffenreid's peers at other companies?
Mike Degraffenreid's peers at other companies are
Marina Busuek,
Paul Wash,
Dan Comer,
Soufyan Jerhaoui,
Shashank Kulkarni,
Bin Xu,
and
Rakesh Thorat.